FDA
approval
· 2022-06-17
FDA Approved: BUPRENORPHINE AND NALOXONE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
Summary
The FDA approved a supplemental application for buprenorphine and naloxone from Rhodes Pharmaceuticals L.P., related to its regulatory approval for opioid use d…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE AND NALOXONE (BUPRENORPHINE AND NALOXONE)